新型コロナウイルスのmRNAワクチンを開発したことで知られる製薬企業のモデルナが、季節性インフルエンザのmRNAワクチン「mRNA-1010」の第3相臨床試験で、従来の標準的なインフルエンザワクチンよりも相対的に26.6％高い有効性が確認されたと発表 ...

Moderna, Inc.のプレスリリース（2025年6月6日 13時00分）モデルナ・ジャパン、「スパイクバックス®筋注シリンジ12歳以上用」において、LP.8.1に対応し ...

Moderna also said it had found that its shot was equal or superior to Sanofi's high-dose flu vaccine in a separate early head-to-head study. 広告 - スクロール後に記事が続きます ...

(Yicai Global) July 5 -- Moderna is set to announce investment in China of as much as USD1 billion, the US vaccine maker’s first in the country, according to sources. Chief Executive Stéphane Bancel ...

Moderna, Inc.のプレスリリース（2023年2月24日 18時33分）モデルナ・ジャパン「Moderna Meets Music」アンバサダーFANTASTICS中島颯太の就任式開催 ...

TOKYO - The foreign matter found in some lots of Moderna Inc.'s vaccine distributed but suspended from use in Japan was confirmed to be stainless steel that was mixed during the manufacturing process, ...

Takeda Pharmaceutical Co. said Thursday it has begun clinical trials in Japan of a COVID-19 vaccine candidate by U.S. biotech firm Moderna Inc. with an eye to distributing it in the first half of this ...

アメリカのバイオテクノロジー企業・Modernaが開発した新型コロナウイルスワクチンは臨床試験で94.1％の有効性を示し、アメリカだけでなくEUでも ...

Social media users have been sharing a meme which seeks to undermine COVID-19 vaccinations by casting doubt on whether it is possible to make a 95% effective coronavirus vaccine in 10 months, when ...